CymitQuimica logo

CAS 863288-34-0

:

CJC 1295

Descrizione:
CJC-1295 è un peptide sintetico che funge da analogo dell'ormone di rilascio dell'ormone della crescita (GHRH). Viene utilizzato principalmente in contesti di ricerca per studiare i suoi effetti sulla secrezione dell'ormone della crescita e le potenziali applicazioni terapeutiche. CJC-1295 è caratterizzato dalla sua capacità di stimolare la ghiandola pituitaria a rilasciare ormone della crescita, il che può portare a un aumento della massa muscolare, perdita di grasso e miglioramento del recupero. Il peptide ha una lunga emivita grazie alla sua modifica, che consente un rilascio sostenuto e un'attività prolungata nel corpo. Viene tipicamente somministrato tramite iniezione sottocutanea. CJC-1295 è spesso studiato nel contesto dell'anti-invecchiamento, del bodybuilding e dei disturbi metabolici, sebbene il suo uso negli esseri umani al di fuori della ricerca non sia approvato dalle agenzie regolatorie. Come per qualsiasi peptide, la purezza, il dosaggio e la via di somministrazione sono fondamentali per la sua efficacia e sicurezza. I ricercatori devono attenersi a linee guida etiche e normative quando maneggiano e studiano questo composto.
Formula:Unspecified
Sinonimi:
  • <span class="text-smallcaps">L</smallcap>-Lysinamide, <smallcap>L</smallcap>-tyrosyl-<smallcap>D</smallcap>-alanyl-<smallcap>L</smallcap>-α-aspartyl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-isoleucyl-<smallcap>L</smallcap>-phenylalanyl-<smallcap>L</smallcap>-threonyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-tyrosyl-<smallcap>L</smallcap>-arginyl-<smallcap>L</smallcap>-lysyl-<smallcap>L</smallcap>-valyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-arginyl-<smallcap>L</smallcap>-lysyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-α-aspartyl-<smallcap>L</smallcap>-isoleucyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-seryl-<smallcap>L</span>-arginyl-N<sup>6</sup>-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-
  • <span class="text-smallcaps">L</smallcap>-Tyrosyl-<smallcap>D</smallcap>-alanyl-<smallcap>L</smallcap>-α-aspartyl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-isoleucyl-<smallcap>L</smallcap>-phenylalanyl-<smallcap>L</smallcap>-threonyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-tyrosyl-<smallcap>L</smallcap>-arginyl-<smallcap>L</smallcap>-lysyl-<smallcap>L</smallcap>-valyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-arginyl-<smallcap>L</smallcap>-lysyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-α-aspartyl-<smallcap>L</smallcap>-isoleucyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-arginyl-N<sup>6</sup>-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-<smallcap>L</span>-lysinamide
  • Cjc 1295
  • L-Tyrosyl-D-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-leucyl-L-seryl-L-arginyl-N6-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-L-lysinamide
  • L-Lysinamide, L-tyrosyl-D-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-leucyl-L-seryl-L-arginyl-N6-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-
Ordinare per

Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 prodotti.
  • CJC-1295

    CAS:
    Formula:C152H252N44O42
    Purezza:95%~99%
    Colore e forma:White to Off-white Powder
    Peso molecolare:3367.897

    Ref: BP-BPPG019

    ne
    Fuori produzione
    Prodotto fuori produzione
  • CJC-1295

    CAS:
    <p>CJC-1295 is a synthetic peptide, which is an analogue of growth hormone-releasing hormone (GHRH). It is synthesized through recombinant DNA technology, which allows for precise control over its sequence and length. This particular peptide is designed to bind to GHRH receptors in the pituitary gland. By activating these receptors, CJC-1295 stimulates the release of growth hormone (GH) into the bloodstream.The primary function of CJC-1295 is to influence the endocrine system, particularly enhancing the release of endogenous growth hormone. It achieves this by increasing the amplitude and frequency of GH pulses without affecting the natural negative feedback mechanisms that regulate GH production. This mode of action distinguishes CJC-1295 from other growth hormone therapies, as it promotes a more physiological pattern of hormone secretion.CJC-1295 is used in various scientific contexts, primarily in research focusing on growth hormone deficiencies, muscle wasting conditions, and certain metabolic disorders. Its ability to increase GH release also makes it a subject of interest in studies related to aging, tissue repair, and regeneration. The longer half-life of CJC-1295 compared to natural GHRH peptides further enhances its applications in research, allowing for more sustained and controlled experimentation.</p>
    Purezza:Min. 95%

    Ref: 3D-FC138107

    5mg
    Fuori produzione
    10mg
    Fuori produzione
    25mg
    Fuori produzione
    50mg
    Fuori produzione
    100mg
    Fuori produzione
    Prodotto fuori produzione